Cargando…

Metformin adherence and discontinuation among patients with type 2 diabetes: A retrospective cohort study

AIMS: To describe discontinuation and adherence to metformin in the United Kingdom. METHODS: This was a retrospective analysis of data from the Clinical Practice Research Datalink database of type 2 diabetes patients aged ≥18 years with ≥1 metformin prescription in 2013. Metformin use was assessed i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yuexin, Weiss, Tracey, Liu, Jinan, Rajpathak, Swapnil, Khunti, Kamlesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7240214/ https://www.ncbi.nlm.nih.gov/pubmed/32461914 http://dx.doi.org/10.1016/j.jcte.2020.100225

Ejemplares similares

Effect of Medication Copayment on Adherence and Discontinuation in Medicare Beneficiaries with Type 2 Diabetes: A Retrospective Administrative Claims Database Analysis
por: Pawaskar, Manjiri D., et al.
Publicado: (2018)

Retrospective Cohort Analysis of the Reduced Burden of Hypoglycemia Associated with Dipeptidyl Peptidase-4 Inhibitor Use in Patients with Type 2 Diabetes Mellitus
por: Tang, Yuexin, et al.
Publicado: (2018)

Dose distribution and up‐titration patterns of metformin monotherapy in patients with type 2 diabetes
por: Iglay, Kristy, et al.
Publicado: (2019)

Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
por: Weiss, Tracey, et al.
Publicado: (2022)

Secondary metformin monotherapy failure in individuals with type 2 diabetes mellitus
por: Weiss, Tracey, et al.
Publicado: (2021)

Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United States
por: Weiss, Tracey, et al.
Publicado: (2020)

Association Between Switching to a High-Deductible Health Plan and Discontinuation of Type 2 Diabetes Treatment
por: Fendrick, A. Mark, et al.
Publicado: (2019)

Budget Impact of Oral Semaglutide Intensification versus Sitagliptin among US Patients with Type 2 Diabetes Mellitus Uncontrolled with Metformin
por: Wehler, Elizabeth, et al.
Publicado: (2020)

Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes
por: An, Jaejin, et al.
Publicado: (2021)

Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
por: Ahmad, Ehtasham, et al.
Publicado: (2020)

Effect of Dipeptidyl Peptidase 4 Inhibitors Used in Combination with Insulin Treatment in Patients with Type 2 Diabetes: A Systematic Review and Meta-analysis
por: Yang, Jin, et al.
Publicado: (2020)

Metformin discontinuation in patients beginning second-line glucose-lowering therapy: results from the global observational DISCOVER study programme
por: Khunti, Kamlesh, et al.
Publicado: (2020)

Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK
por: Lautsch, Dominik, et al.
Publicado: (2019)

Clinical Inertia in People With Type 2 Diabetes: A retrospective cohort study of more than 80,000 people
por: Khunti, Kamlesh, et al.
Publicado: (2013)

Proximal Predictors of Long-Term Discontinuance with Noninsulin Antihyperglycemic Agents
por: Stuart, Bruce C., et al.
Publicado: (2016)

Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis
por: Lautsch, Dominik, et al.
Publicado: (2020)

Patterns of metformin monotherapy discontinuation and reinitiation in people with type 2 diabetes mellitus in New Zealand
por: Horsburgh, Simon, et al.
Publicado: (2021)

Effects of conformance to type 2 diabetes guidelines on health care resource utilization, clinical outcomes, and cost: A retrospective claims analysis
por: Mehta, Rajesh R., et al.
Publicado: (2020)

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy
por: Inzucchi, S. E., et al.
Publicado: (2015)

Use of Metformin and Cardiovascular Effects of New Classes of Glucose-Lowering Agents: A Meta-analysis of Cardiovascular Outcome Trials in Type 2 Diabetes
por: Zaccardi, Francesco, et al.
Publicado: (2021)

Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data
por: Weiss, Tracey J., et al.
Publicado: (2022)

Therapeutic inertia in type 2 diabetes: prevalence, causes, consequences and methods to overcome inertia
por: Khunti, Sachin, et al.
Publicado: (2019)

Addressing Therapeutic Inertia in 2020 and Beyond: A 3-Year Initiative of the American Diabetes Association
por: Gabbay, Robert A., et al.
Publicado: (2020)

Engagement, Retention, and Progression to Type 2 Diabetes: A Retrospective Analysis of the Cluster-Randomised "Let's Prevent Diabetes" Trial
por: Gray, Laura J., et al.
Publicado: (2016)

Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes
por: Heaton, Pamela C., et al.
Publicado: (2016)

Temporal variation of renal function in people with type 2 diabetes mellitus: A retrospective UK clinical practice research datalink cohort study
por: Spanopoulos, Dionysis, et al.
Publicado: (2019)

Association of systolic and diastolic blood pressure and all cause mortality in people with newly diagnosed type 2 diabetes: retrospective cohort study
por: Vamos, Eszter Panna, et al.
Publicado: (2012)

Severity of hypoglycaemia and health‐related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in Europe
por: Pawaskar, Manjiri, et al.
Publicado: (2018)

Adherence to Glyburide and Metformin and Associated Factors in Type 2 Diabetes in Isfahan, Iran
por: Farsaei, Shadi, et al.
Publicado: (2011)

Adherence to metformin in adults with type 2 diabetes: a combined method approach
por: Syafhan, Nadia Farhanah, et al.
Publicado: (2022)

Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
por: Rajpathak, Swapnil N., et al.
Publicado: (2009)

Glycaemic Control after Metformin Discontinuation in Diabetic Patients with a Declining Renal Function
por: Leyco, Theresa, et al.
Publicado: (2017)

Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add‐on to metformin in patients with type 2 diabetes
por: Inzucchi, Silvio E., et al.
Publicado: (2020)

Dietary Recommendations for the Prevention of Type 2 diabetes: What Are They Based on?
por: Carter, Patrice, et al.
Publicado: (2012)

Addressing Therapeutic Inertia: Development and Implementation of an Electronic Health Record–Based Diabetes Intensification Tool
por: Pantalone, Kevin M., et al.
Publicado: (2023)

Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes
por: Wang, Jingya, et al.
Publicado: (2021)

Effect of Cost and Formulation on Persistence and Adherence to Initial Metformin Therapy for Type 2 Diabetes
por: Flory, James H., et al.
Publicado: (2020)

Evaluation of the Diabetes Screening Component of a National Cardiovascular Risk Assessment Programme in England: a Retrospective Cohort Study
por: Palladino, Raffaele, et al.
Publicado: (2020)

Discontinuation of metformin to prevent metformin-induced high colonic FDG uptake: is 48 h sufficient?
por: Schreuder, Nanno, et al.
Publicado: (2020)

Analysis of the Adherence and Safety of Second Oral Glucose-Lowering Therapy in Routine Practice From the Mediterranean Area: A Retrospective Cohort Study
por: Vlacho, Bogdan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ufje0pe0q7vuv66to98nt7jr9r